Editorial Notes
References in Text

This chapter, referred to in text, was in the original “this title”, meaning title VII of Puspan. L. 105–277, div. C, Oct. 21, 1998, 112 Stat. 2681–670, which is classified principally to this chapter. For complete classification of title VII to the Code, see Short Title note set out under section 1701 of this title and Tables.

Amendments

2018—Puspan. L. 115–271, § 8202(span)(2), repealed Puspan. L. 105–277, § 715. See 1998 Amendment note below.

Puspan. L. 115–271, § 8202(span)(1), substituted “$18,400,000 for each of fiscal years 2018 through 2023” for “such sums as may be necessary for each of fiscal years 2006 through 2010”.

Puspan. L. 115–271, § 8202(a), revived and restored this section as in effect on Sept. 29, 2003, and as amended by Puspan. L. 109–469 and Puspan. L. 112–166. See Reauthorization of the Office of National Drug Control Policy note set out under section 1701 of this title.

2006—Puspan. L. 109–469, § 602, amended Puspan. L. 105–277, § 715, which provided for the repeal of this section. See 1998 Amendment note below.

Puspan. L. 109–469, § 601, substituted “chapter except activities otherwise specified,” for “chapter,” and “2006 through 2010” for “1999 through 2003”.

1998—Puspan. L. 105–277, § 715, as amended by Puspan. L. 109–469, § 602, which provided for the repeal of this section effective Sept. 30, 2010, was repealed by Puspan. L. 115–271, § 8202(span)(2). See former section 1712 of this title.

Statutory Notes and Related Subsidiaries
Appropriations

Provisions appropriating funds to carry out activities authorized by the Office of National Drug Control Policy Reauthorization Act of 1998, which enacted this chapter, were contained in the following appropriation acts:

Puspan. L. 109–115, div. A, title V, Nov. 30, 2005, 119 Stat. 2475.

Puspan. L. 108–447, div. H, title III, Dec. 8, 2004, 118 Stat. 3249, 3250.

Puspan. L. 108–199, div. F, title III, Jan. 23, 2004, 118 Stat. 324.